These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20687102)

  • 41. A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.
    Johnson SM; Haberberger J; Galeotti J; Ramkissoon L; Coombs CC; Richardson DR; Foster MC; Duncan D; Zeidner JF; Ferguson NL; Montgomery ND
    Blood Cancer J; 2023 Jun; 13(1):96. PubMed ID: 37365170
    [No Abstract]   [Full Text] [Related]  

  • 42. Suppressor mutation analysis combined with 3D modeling explains cohesin's capacity to hold and release DNA.
    Xu X; Kanai R; Nakazawa N; Wang L; Toyoshima C; Yanagida M
    Proc Natl Acad Sci U S A; 2018 May; 115(21):E4833-E4842. PubMed ID: 29735656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers.
    Mondal G; Stevers M; Goode B; Ashworth A; Solomon DA
    Nat Commun; 2019 Apr; 10(1):1686. PubMed ID: 30975996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia.
    Barjesteh van Waalwijk van Doorn-Khosrovani S; Spensberger D; de Knegt Y; Tang M; Löwenberg B; Delwel R
    Oncogene; 2005 Jun; 24(25):4129-37. PubMed ID: 15806161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of splice factor and cohesin complex mutations in pediatric myelodysplastic syndrome.
    Obenauer JC; Kavelaars FG; Sanders MA; Hoogenboezem RM; de Vries AC; van Strien PM; de Haas V; Locatelli F; Hasle H; Valk PJ; Touw IP; van den Heuvel-Eibrink MM
    Haematologica; 2016 Dec; 101(12):e479-e481. PubMed ID: 27587384
    [No Abstract]   [Full Text] [Related]  

  • 46. Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes.
    Leroy H; Roumier C; Grardel-Duflos N; Macintyre E; Lepelley P; Fenaux P; Preudhomme C
    Blood; 2002 May; 99(10):3848-50. PubMed ID: 11986246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rings and Bricks: Expression of Cohesin Components is Dynamic during Development and Adult Life.
    Bettini LR; Graziola F; Fazio G; Grazioli P; Scagliotti V; Pasquini M; Cazzaniga G; Biondi A; Larizza L; Selicorni A; Gaston-Massuet C; Massa V
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New mechanisms of AML1 gene alteration in hematological malignancies.
    Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
    Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
    Chesnais V; Arcangeli ML; Delette C; Rousseau A; Guermouche H; Lefevre C; Bondu S; Diop M; Cheok M; Chapuis N; Legros L; Raynaud S; Willems L; Bouscary D; Lauret E; Bernard OA; Kosmider O; Pflumio F; Fontenay M
    Blood; 2017 Jan; 129(4):484-496. PubMed ID: 27856460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML.
    Schuler E; Frank F; Hildebrandt B; Betz B; Strupp C; Rudelius M; Aul C; Schroeder T; Gattermann N; Haas R; Germing U
    Leuk Res; 2018 Feb; 65():1-4. PubMed ID: 29216536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.
    Rowley JD; Reshmi S; Sobulo O; Musvee T; Anastasi J; Raimondi S; Schneider NR; Barredo JC; Cantu ES; Schlegelberger B; Behm F; Doggett NA; Borrow J; Zeleznik-Le N
    Blood; 1997 Jul; 90(2):535-41. PubMed ID: 9226152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The cohesin REC8 prevents illegitimate inter-sister synaptonemal complex assembly.
    Ishiguro K; Watanabe Y
    EMBO Rep; 2016 Jun; 17(6):783-4. PubMed ID: 27170621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct sequences on 11q13.5 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patients.
    Zatkova A; Ullmann R; Rouillard JM; Lamb BJ; Kuick R; Hanash SM; Schnittger S; Schoch C; Fonatsch C; Wimmer K
    Genes Chromosomes Cancer; 2004 Apr; 39(4):263-76. PubMed ID: 14978788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies.
    Tosi S; Giudici G; Mosna G; Harbott J; Specchia G; Grosveld G; Privitera E; Kearney L; Biondi A; Cazzaniga G
    Genes Chromosomes Cancer; 1998 Mar; 21(3):223-9. PubMed ID: 9523197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cloning and characterization of two Arabidopsis genes that belong to the RAD21/REC8 family of chromosome cohesin proteins.
    Dong F; Cai X; Makaroff CA
    Gene; 2001 Jun; 271(1):99-108. PubMed ID: 11410371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms.
    Mullenders J; Aranda-Orgilles B; Lhoumaud P; Keller M; Pae J; Wang K; Kayembe C; Rocha PP; Raviram R; Gong Y; Premsrirut PK; Tsirigos A; Bonneau R; Skok JA; Cimmino L; Hoehn D; Aifantis I
    J Exp Med; 2015 Oct; 212(11):1833-50. PubMed ID: 26438359
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic Interactions Between the Meiosis-Specific Cohesin Components, STAG3, REC8, and RAD21L.
    Ward A; Hopkins J; Mckay M; Murray S; Jordan PW
    G3 (Bethesda); 2016 Jun; 6(6):1713-24. PubMed ID: 27172213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
    Damm F; Chesnais V; Nagata Y; Yoshida K; Scourzic L; Okuno Y; Itzykson R; Sanada M; Shiraishi Y; Gelsi-Boyer V; Renneville A; Miyano S; Mori H; Shih LY; Park S; Dreyfus F; Guerci-Bresler A; Solary E; Rose C; Cheze S; Prébet T; Vey N; Legentil M; Duffourd Y; de Botton S; Preudhomme C; Birnbaum D; Bernard OA; Ogawa S; Fontenay M; Kosmider O
    Blood; 2013 Oct; 122(18):3169-77. PubMed ID: 24047651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A kinase-dependent role for Haspin in antagonizing Wapl and protecting mitotic centromere cohesion.
    Liang C; Chen Q; Yi Q; Zhang M; Yan H; Zhang B; Zhou L; Zhang Z; Qi F; Ye S; Wang F
    EMBO Rep; 2018 Jan; 19(1):43-56. PubMed ID: 29138236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia.
    Euba B; Vizmanos JL; García-Granero M; Aranaz P; Hurtado C; Migueliz I; Novo FJ; García-Delgado M
    Leuk Lymphoma; 2012 Jun; 53(6):1230-3. PubMed ID: 22080757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.